Healio31m
Adding anifrolumab superior to standard therapy alone, maintains remission in lupus
Adding anifrolumab to standard treatment for systemic lupus erythematosus led to faster achievement of low disease activity ...
CeSPIACE: A broad spectrum peptide inhibitor against variable SARS-CoV-2 spikes
SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 ...
Phage identification tool shortens the search for specific viruses to combat dangerous bacteria
A newly developed laboratory tool can, within hours, help to identify specific viruses which can be used to destroy variants ...
Pharmabiz14d
Androgen receptor non-canonical domain binding degrader for treatment of relapsed, refractory castration-resistant prostate cancer
K. Sadasivan Pillai Wednesday, March 5, 2025, 08:00 Hrs [IST] ...
Targeted Oncology1d
Understanding the Significance of ESR1 Mutations in Breast Cancer
Seth Wander, MD, PhD, discusses the significance of ESR1 mutations in patients with hormone receptor–positive, HER2-negative ...
Rolling Out5d
8 ways diet and lifestyle shape your brain chemistry
Discover eight ways your diet and lifestyle directly influence neurotransmitter balance, affecting mood, focus, sleep quality ...
Rheumatology Advisor1d
February 2025 Recap: Drug Pipeline Updates
The table is a review of notable updates that occurred in February 2025 for investigational products in development.
Medscape1d
Cannabis Is Interfering With the Heart
Evidence is stacking up about the influence of cannabinoids on cardiovascular disease, and newer, synthetic options are ...
News Medical on MSN4d
FXR cyclic peptide antagonists as a novel strategy for MASH treatment
In this study, the authors first used an AlphaScreen assay to identify a series of tryptophan-based cyclic peptide compounds with FXR-antagonistic activity, specifically those modified with a ...